Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Other Working Capital Changes (2010 - 2026)

Lite Strategy (LITS) posted Other Working Capital Changes of -$334000.0 for Q1 2026, up 31.28% on a QoQ basis from -$486000.0 in Q4 2025, and up 1.47% year-over-year from -$329145.3 in Q1 2025.

Analysis

Lite Strategy (LITS) Other Working Capital Changes (2010 - 2026) Analysis & Trends

Lite Strategy has reported Other Working Capital Changes for 17 years, with the latest figure at -$334000.0 in Q1 2026.

  • On a quarterly basis, Other Working Capital Changes rose 1.47% year-over-year to -$334000.0 in Q1 2026; TTM through Mar 2026 was $452000.0, a 103.9% increase from a year earlier, with the FY2025 full-year figure at -$2.2 million, up 84.21% from the prior year.
  • Other Working Capital Changes was -$334000.0 for Q1 2026 at Lite Strategy, up from -$486000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $78.4 million in Q2 2020, with the low at -$64.9 million in Q3 2023.
  • Average Other Working Capital Changes over 5 years is -$1.0 million, with a median of -$1.3 million recorded in 2022.
  • The largest YoY upside for Other Working Capital Changes was 650.0% in 2022 against a maximum downside of 1397.14% in 2022.
  • Over 5 years, Other Working Capital Changes stood at $429000.0 in 2022, then sank by 139.86% to -$171000.0 in 2023, then decreased by 13.45% to -$194000.0 in 2024, then plunged by 150.52% to -$486000.0 in 2025, then surged by 31.28% to -$334000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$334000.0 (Q1 2026), -$486000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -334,000.00
Mar 31, 2026 -334,000.00
Dec 31, 2025 -486,000.00
Dec 31, 2025 -486,000.00
Sep 30, 2025 1.31 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2025 -33,000.00
Jun 30, 2025 -33,000.00
Mar 31, 2025 -339,000.00
Mar 31, 2025 -339,000.00
Dec 31, 2024 -194,000.00
Dec 31, 2024 -194,000.00
Sep 30, 2024 -1.58 Mn
Sep 30, 2024 -1.58 Mn
Jun 30, 2024 -9.47 Mn
Jun 30, 2024 -9.47 Mn
Mar 31, 2024 -3.44 Mn
Mar 31, 2024 -3.44 Mn
Dec 31, 2023 -171,000.00
Dec 31, 2023 -171,000.00